-
Free webinar - Unpacking the Modernization of Cosmetics Regulation Act of 2022
-
15 Replies
-
January 25
-
Many thanks, Phil! That will be an interesting webinar
-
Thanks @PhilGeis
-
Thanks for the 411 Phil.
-
Today!
-
Don’t know if you guys sat in - some points cam across to me that folks here should understand
- safety that all must substantiate is for product, not ingredients per se
- adverse event reporting can be by website - assume company’s website as in
“none reported”
- FDA recall authority is for Class I recalls, the most serious - almost all
cosmetic recalls are the less serious classes II or III.
- A lot of stuff is hanging fired until FDA sets up the regs - GMP’s big sand small business, fragrance allergen labeling (but might go to school on EU) -
Interesting. Unfortunately, my IFSCC webinar ran long so I didn’t get to see this one.
-
Great Webinar. Lots of good information.
-
I was not able to attend. Did they elaborate on exactly what is required for the Safety Assessment?
-
@MarkBroussard
Sorry Mark - you would have found it interesting.
Nope. That’s on FDA’s list of development items. They emphasized product in place of ingredient but suggested ingredient news could screw up a product assessment. -
@MarkBroussard They are sending a recording of the seminar and the slides at some point. I will post the links.
-
@Microformulation
They received > 200 questions. hope they’ll answer those they can -
Thanks! Very much appreciate it
-
PhilGeis said:@Microformulation
They received > 200 questions. hope they’ll answer those they canIn my experience, those 200 questions usually distill down to 20 or so lucid questions, repeats of the same question, and questions from those who don’t have the foundation to follow the webinar.
-
@Microformulation - based on my experience, half of the questions will be “will this be recorded?” and “can I get a copy of the slides?” lol
Log in to reply.